The basis for breakthroughs

Aldevron is a premier manufacturing partner providing critical nucleic acids and proteins used to make gene and cell therapies, gene editing technologies, DNA and RNA vaccines. Its custom development and manufacturing services have given scientists around the world the essential components to accelerate their research and develop revolutionary treatments for millions of people. For more than 20 years, Aldevron’s industry leading technology and expertise has supported thousands of innovations, including the linearized DNA template for Moderna’s COVID-19 vaccine. 

Aldevron was founded in 1998 by Michael Chambers and John Ballantyne. In 2021, Aldevron became part of the Danaher Family.